Search research articles
Contact Us
Filters
Showing results (221-230 of 313) with videos related to
Page
of 32
Sort By:
Enzyme
|
January 1, 1986
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
C Fabris, G Del Favero, A Panucci, et al.
American Journal of Clinical Pathology
|
November 1, 1994
Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease. Relationship with cholestasis and functioning hepatic mass
M Pirisi, E Falleti, C Fabris, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology
|
January 1, 1990
Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer
C Fabris, D Basso, T Meggiato, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis
C Fabris, M Pirisi, G Soardo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 1, 1995
Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C
G Soardo, M Pirisi, M Fonda, et al.
Acta Bio-Medica De L'Ateneo Parmense : Organo Della Societa Di Medicina E Scienze Naturali Di Parma
|
June 27, 2001
[CRIB score: mortality, morbidity, and long-term neurologic development]
A Coscia, G Prandi, S Borgione, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 13, 2001
Serum iron indices as a measure of iron deposits in chronic hepatitis C
C Fabris, P Toniutto, C A Scott, et al.
Minerva Medica
|
April 14, 1986
[The role of CEA, CA 19-9 and TPA in the diagnosis of pancreatic cancer. Evaluation by discriminant analysis]
D Basso, C Fabris, G Del Favero, et al.
The Italian Journal of Gastroenterology
|
February 1, 1990
How does liver dysfunction influence serum CA 19-9 in pancreatic cancer?
D Basso, C Fabris, G Del Favero, et al.
Minerva Pediatrica
|
December 31, 1984
[Surveillance of congenital malformations. Experience relative to the period from December, 1978 to December, 1981]
L Gagliardi, D Licata, E Garzena, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 313) with videos related to
Sort By:
Page
of 32
Enzyme
|
January 1, 1986
Serum elastase 1 and immunoreactive trypsin in chronic pancreatic disease: is there any relationship with trypsin inhibitors?
C Fabris, G Del Favero, A Panucci, et al.
American Journal of Clinical Pathology
|
November 1, 1994
Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease. Relationship with cholestasis and functioning hepatic mass
M Pirisi, E Falleti, C Fabris, et al.
International Journal of Pancreatology : Official Journal of the International Association of Pancreatology
|
January 1, 1990
Different role of liver dysfunction and damage in increasing serum CA 19-9, TPA, and CEA in patients with pancreatic cancer
C Fabris, D Basso, T Meggiato, et al.
Journal of Cancer Research and Clinical Oncology
|
January 1, 1994
Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis
C Fabris, M Pirisi, G Soardo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
|
August 1, 1995
Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C
G Soardo, M Pirisi, M Fonda, et al.
Acta Bio-Medica De L'Ateneo Parmense : Organo Della Societa Di Medicina E Scienze Naturali Di Parma
|
June 27, 2001
[CRIB score: mortality, morbidity, and long-term neurologic development]
A Coscia, G Prandi, S Borgione, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 13, 2001
Serum iron indices as a measure of iron deposits in chronic hepatitis C
C Fabris, P Toniutto, C A Scott, et al.
Minerva Medica
|
April 14, 1986
[The role of CEA, CA 19-9 and TPA in the diagnosis of pancreatic cancer. Evaluation by discriminant analysis]
D Basso, C Fabris, G Del Favero, et al.
The Italian Journal of Gastroenterology
|
February 1, 1990
How does liver dysfunction influence serum CA 19-9 in pancreatic cancer?
D Basso, C Fabris, G Del Favero, et al.
Minerva Pediatrica
|
December 31, 1984
[Surveillance of congenital malformations. Experience relative to the period from December, 1978 to December, 1981]
L Gagliardi, D Licata, E Garzena, et al.
Page
of 32